ABIONYX Pharma and OLON enter strategic manufacturing partnership
Abionyx Pharma SA announced a strategic manufacturing partnership with Olon to prepare its Cer-001 biologic for regulatory approval and commercial supply. Manufacturing will take place at two Olon sites in France.
Abionyx Pharma SA said on Oct. 7 that it and OLON have entered into a strategic manufacturing partnership for CER-001 as it prepares the biologic for regulatory approval and commercial supply. Manufacturing activities will be carried out at two OLON sites in France.